Astellas Pharma Inc banner

Astellas Pharma Inc
F:YPHA

Watchlist Manager
Astellas Pharma Inc Logo
Astellas Pharma Inc
F:YPHA
Watchlist
Price: 13.4 EUR -0.74% Market Closed
Market Cap: €24B

Wall Street
Price Targets

YPHA Price Targets Summary
Astellas Pharma Inc

Wall Street analysts forecast YPHA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for YPHA is 11.61 EUR with a low forecast of 8.2 EUR and a high forecast of 15.34 EUR.

Lowest
Price Target
8.2 EUR
39% Downside
Average
Price Target
11.61 EUR
13% Downside
Highest
Price Target
15.34 EUR
14% Upside
Astellas Pharma Inc Competitors:
Price Targets

Revenue
Forecast

5% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
5% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Astellas Pharma Inc's revenue is 5%. The projected CAGR for the next 3 years is 1%.

Operating Income
Forecast

5% / Year
Past Growth
68% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
5% / Year
Past Growth
68% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

For the last 13 years the compound annual growth rate for Astellas Pharma Inc's operating income is 5%. The projected CAGR for the next 1 year is 68%.

Net Income
Forecast

-3% / Year
Past Growth
68% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat
-3% / Year
Past Growth
68% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat

For the last 13 years the compound annual growth rate for Astellas Pharma Inc's net income is -3%. The projected CAGR for the next 3 years is 68%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is YPHA's stock price target?
Price Target
11.61 EUR

According to Wall Street analysts, the average 1-year price target for YPHA is 11.61 EUR with a low forecast of 8.2 EUR and a high forecast of 15.34 EUR.

What is Astellas Pharma Inc's Revenue forecast?
Projected CAGR
1%

For the last 13 years the compound annual growth rate for Astellas Pharma Inc's revenue is 5%. The projected CAGR for the next 3 years is 1%.

What is Astellas Pharma Inc's Operating Income forecast?
Projected CAGR
68%

For the last 13 years the compound annual growth rate for Astellas Pharma Inc's operating income is 5%. The projected CAGR for the next 1 year is 68%.

What is Astellas Pharma Inc's Net Income forecast?
Projected CAGR
68%

For the last 13 years the compound annual growth rate for Astellas Pharma Inc's net income is -3%. The projected CAGR for the next 3 years is 68%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett